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Abstract
This study aimed to investigate the incidence of the  influenza virus, and its interspecies
transmission cycle among horses. A comparative serological survey was performed
using horse sera  following challenge with both specific (equine) and non-specific (human)
influenza virus strains. Bleedings of the 22 horses were performed during the years
1999 and 2000. Following treatment with kaolin (20%), added in rooster erythrocytes
suspension (50%), for removal of non-specific antibodies, sera were titered against
both Human and Equine Influenza virus, by the Hemagglutination Inhibition
Assay(HI), recommended by WHO. The HI results  of  horse serological responses
demonstrate cross reaction between both the specific strain, A/Eq1 (H7N7) ( 62.75%)
and A/Eq2 (H3N8) (60.65%), and the non- specific strains, type A (H1N1) (79.5%)
and  A (H3N2) (94.45%) and type B (77.75%). It was noteworthy the high percentage
of protection responses in equine sera aginst the non-specific strains, as compared with
the specific strains. This finding suggests direct interspecies transmission of  influenza
virus as  zoonotic viruses, particulary for the  type B strain which is considered  restricted
to humans. It was the first report, in Brazil. Further studies are required to achieve a
complete understanding of the incidence of influenza in our environment.
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Introduction
The most common virus associated with
acute Infectious of  Upper Respiratory Tract
Disease (IURD), in horses, is the influenza virus.1
This virus was isolated from horses for the first
time in 1956, in Prague (Czechoslovakia) and
was identified as A/Eq/Prague/1/56
(Heq1Neq1). In 1963, a new strain of equine
influenza was reported in Miami (USA) and
named A/Eq/Miami/1/63 (Heq2Neq2).
Today, these equine strains are denominated
H7N7 and H3N8, respectively, by the WHO
Expert Committee.2
In Brazil, equine influenza was reported
in São Paulo State, in 1988, by our group.3 In
1969, 1976 and 1986, this virus was also isolated
from horses in Rio de Janeiro State. The latter
report presented the observation of  an antigenic
variation of the A/Eq2 Brazilian strain
compared with the reference strain, A/Eq/
Miami/1/63 (H3N8).4,5
 The existence of antigenic variations
among equine H3N8 influenza virus
hemagglutinins in horses from  different
hemispheres has been recently reported7,13.
Although the equine influenza virus is believed
to be stable, its antigenic variations have been
observed in infected horses imported from
different countries. Virus stability is probably
associated with the specificity of the circulating
strains in each country. Alternatively, direct
infection of horses by avian influenza strains may
occur, without virus genetic reassortment, since
the equine influenza virus is derived primarily
from birds.6,7 The appearance of  a new totally
unknown emergent strain of influenza virus in
horses may  act as a warning with regarding to
what could happen to the human species. The
human immune system would certainly not to
Correspondence to:
DALVA ASSUNÇÃO PORTARI MANCINI
Laboratório de Virologia
Instituto Butantan
Avenida Vital Brazil, 500
São Paulo - SP
labvirol@butantan.gov.br
Received: 21/05/2003
Accepted: 24/05/2004
Brazilian Journal of Veterinary Research and Animal Science (2004) 41:379-383
ISSN printed: 1413-9596
ISSN on-line: 1678-4456
380
Braz J vet Res anim Sci 41(6) 2004
be able to recognize the virus and a viral disease
would be inevitable to this species.
Infections  of the influenza virus occurring
in a direct manner from the avian to mammalian
species via the natural hosts have  been reported
. Scientists have been frequently suggested that
the pigs are  responsible for the virus genetical
reassortment that  facilitates avian influenza virus
adaptation to mammalian species.10,11
Although the type A influenza virus is
very easialy spread in avian and mammalian
species, type B is reported only in a few animal
species, such as monkeys and, more recently,  in
seals.12,13,14 This fact suggests a threat to humans,
since reservoirs facilitate viral genetic
recombinations, as currently occurs with influenza
A, making it the most epidemic virus.
Due to its minor circulation among the
animal species, the type B influenza virus is
currently considered the more stable influenza
virus. The genetic variation of  this virus, which
remains poorly understood, does not seem
contribute greatly to its evolution.13,15,16 Lai  et
al.6, demonstrated  similarities between type B
and equine 2 influenza with regarding to their
evolutionary pathways, as the result of slower
antigenic drift. Thus, more studies concerning
the maintenance of influenza in natural hosts are
required, particularly to investigate the possibility
that this virus has itself   become a zoonotic virus.
By definition, the zoonosis is a disease provoked
by the same agent either in humans or vertebrate
animals. Viral zoonosis have been emerging and
re-emerging throughout history and cause
serious disease outbreaks in human populations.
Emerging viral zoonotic infections with hosts
in native species are a hazard for humans. In the
past and now, the rabies virus has presented such
a problem and, currently, the influenza and hanta
viruses have been proposed to form part of
this infections group17.
“New” viral diseases can arise when
viruses broaden their host range and can develop
high mutation rates, type A influenza is an
example of  such a virus.18  A serological survey
realized in Lagos and Ibandan, Nigeria, 1990,
showed that 87% of horses responded to the
human influenza type A(H3N2).18 In this study,
higher levels of antibodies against human
influenza types A and B were detected in horse
sera. Such a finding has also been observed in
primates such as non-human (monkeys).12
The investigation on the incidence of the
influenza virus and its interspecies transmission
among horses represented the objective of this
work.
Material and Methods
Animals
 Twenty-two adult horses (Equus caballus)
were utilized in the study. One group that was
vaccinated with bivalent equine influenza vaccine,
and another that was not vaccinated against
influenza, were evaluated by a serological test.
The animals were kept in the Clínica Médica da
Faculdade de Medicina Veterinária e Zootecnia
da Universidade de São Paulo during the time
of  experiments.
Serum samples
Samples were collected from the external
jugular vein of the horses, using the vacuum
system and disposable  needles (40 X 9 mm).
After blood coagulation and retraction, the
samples were centrifuged (Baby Excelsa 206/I
centrifuge) at 260g for 15min. The serum samples
were inactivated at 56°C for 30min and treated
with Kaolin (20%) added to rooster blood
(50%) for removal of  non-specific antibodies.
The samples were kept at –70°C until the time
of the serological test.
Serology – hemagglutination inhibition test (HI)15
This test is based on the inhibition of the
hemagglutinating action of  the virus by  specific
antibodies. After treatment, duplicate dilutions of
sera were carried out in series, in “V” bottom
microplates. Antigens of  human and equine
influenza virus, cultived in MDCK cells, containing
4 hemagglutinating units, was added to the cavities.
After one-hour of reaction at room temperature,
5% rooster erythrocytes were added to them.
Reading was processed after 30 min. The
reciprocal of the last dilution which elicited the
hemagglutination inhibition was considered as
the antibody titer. Those sera presenting antibody
titers equal or superior to 1/20 were considered
Mancini, D. A. P. et al.
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Figure 1
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Table 1
Influenza IH titers detected in serum of horses vaccinated with equine
influenza virus(A/Eq1 and A/Eq2)
Eq1:A/Eq1/SP/56(H7N7); Eq2:A/Eq2/SP/85(H3N8; A/SP/1/91(H1N1
A/SP/2/95(H3N2); B/90 B/SP/1/90; B/83: B/URSS/83(from
Bethesda,MA,USA)
Table 2
Influenza IH titers detected in serum of unvaccinated horses with equine
influenza virus
Eq1:A/Eq1/SP/56(H7N7); Eq2:A/Eq2/SP/85(H3N8); A/SP/1/91 (H1N1)
A/SP/2/95(H3N2); B/90: B/SP/1/90; B/83: B/URSS/83(from
Bethesda,MA,USA)
                     Strains of Influenza virus 
    Animals EQ1            EQ2             H1N1         H3N2             B/90               B/83 
1(Mirinda) 290.9 360 392.7 309.1 226.8 70.9 
2(Zarolho) 208 192 44 48 618.7 76 
3(Lunga) 344.2 592.7 0 72.7 296 47.3 
4(Zito) 160 160 160 80 533.3 106.7 
5(Joana D’Ar) 40 40 266.7 40 160 40 
6(Lambari) 0 10 320 80 40 0 
7(Dida) 40 13.3 80 40 93.3 6.7 
8(Bambam) 53.3 93.3 66.7 66.7 333.3 66.7 
9(Alamis) 46.7 26.7 66.7 73.3 173.3 40 
10(Dodge) 53.3 93.3 80 80 280 40 
11(Conan) 93.3 93.3 66.7 40 693.3 66.7 
12(Grizzli) 80 160 80 320 40 160 
13(Castanho) 53.3 77.1 140 93.3 110 60 
médium/titers 112.53 147.05 135.65 103.31 276.76 60.07 
                                                   Strains of Influenza virus 
Animals      EQ1          EQ2          H1N1       H3N2          B/90          B/83 
14(Malaga) 0 0 142.2 82.2 0 0 
15(Tupi) 90.8 346.7 32.7 660 170 25 
16(Treka) 0 0 680 120 0 0 
 17(Bady) 0 106.7 0 56.7 23.3 0 
18(Príncipe) 0 80 290 280 160 0 
19(Garimpo) 0 13.3 53.3 146.7 46.7 0 
20(Alazão) 46.7 55 80 80 200 20 
21(Vivi) 40 0 20 20 160 0 
22(Tordilho) 0 0 113.3 70 0 0 
medium/titers 19.72 66.85 156.83 168.4 84.44 5 
Results
Table 1 and table 2 demonstrate the
results obtained by the HI test to show the
responses of the serum horse to the specific
strains (Table 1) of  influenza virus, as well as the
non-specific strains (Table 2). Data shown in
Table 1 refer to the animals vaccinated against
either A/Eq1(H7N7) or A/Eq2(H3N8) equine
influenza strains. HI antibody levels against specific
strain components of the equine influenza
vaccine are represented by the mean titer detected
in horse sera; 112.53HIU for A/Eq1/SP/1/
1956(H7N7) and 147.05HIU for A/Eq2/SP/
1/1985(H3N8). Strains of human influenza virus
antibody titers were 135.65HIU for A/SP/1/
1991(H1N1), 103.31HIU for A/SP/2/
1995(H3N2), 60.07HIU for B/URSS/1983
(Bethesda, MA, USA) and 276.76HIU for B/
SP/1/1990. Table 2 shows the mean titers
detected in the sera of horses which did not
receive the vaccine against any strains of equine
and human influenza virus; 19.72HIU for A/
Eq1/SP/1/1956 (H7N7), 66.85HIU for A/
Eq2/SP/1/1985 (H3N8), 156.83HIU for A/
SP/1/1991 (H1N1), 168.4HIU for A/SP/2/
1995 (H3N2), 5HIU for B/URSS/1983
(Bethesda, MA ,USA) and 84.44HIU for B/
SP/1/1990.
 The percentages of horses presenting
HI protector antibodies (³40HIU), for both
specific and non-specific strains of influenza virus
are demonstrated in the figure 1.
as positive and titers5 40HIU were considered
protector antibody. For all components the
volume of 0.025ml was constant.
Virus
Influenza virus strains, isolated from
human and horses in the city of  São Paulo,
State of  São Paulo, Brazil, were maintained
in MDCK cell cultures through successive
passages. The following human and equine
influenza strains were used: A/SP/1/
91(H1N1), A/SP/2/95(H3N2), A/Eq1/
SP/56(H7N7), A/Eq2/SP/1/85(H3N8),
B/SP/1/90. The B/URSS/83 (from
Bethesda, MA, USA),  was the standard strain
used.
Anti-human influenza protector antibody detected in horses as a zoonotic viruses
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Discussion and Conclusion
The results obtained from the serological
evaluations realized in this study demonstrated
that horses respond to the specific influenza
strains (equine) as well as to non-specific influenza
(humans) strains. When the group of  vaccinated
animals (Table 1) was evaluated, the mean titer
of antibodies to the influenza virus were almost
equivalent for both strains. One horse, however,
did not respond to the equine strains, but did to
the human strains of  influenza virus.
The unvaccinated horses (Table 2)
presented lower antibody titers in response to
the equine strains compared with the vaccinated
group. However, these animals had higher mean
antibody titers against the human influenza strains
than against the specific equine strains. These data
suggest that the horses have been more exposed
to human influenza, probably by their feeders.
In this group, a prevalence of the A(H3) subtype,
originated from humans as well as from horses,
was observed. Just two animals did not respond
to the human influenza strains, one did not
respond to the A(H1N1) strain and one did not
have a protector antibodies level  to any human
influenza type A strain. The latter animal,
however, did have a response to the type B
strain (titer ³160 HIU) and with A(H7N7)(titer
³40 HIU).
It is important to highlight the low
prevalence of the equine strain A/Eq1(H7N7),
which showed a mean titer of just 19.72HIU
or mean protector antibody level of 33.30% in
unvaccinated horse sera (Table 2, Figure1). These
results are in agreement with a recent report
demonstrating a low circulation of the A(H7N7)
strain in equine populations during serological
survey.19
Taking into account the high percentages
of protector antibodies against influenza viruses
(titer ³40 HIU), including the type B virus,
detected in these animal sera (Figure 1), it is
possible to deduce which of these horses were
constantly stimulated by these viruses,
independently of vaccination. Similar findings
by Olaleye et al.18, who reported the presence
of human influenza virus in horses during a
serological survey realized in Nigeria, in 1999.
However, little current data regarding this
subject can be found in the literature. In addition
to the studies cited, various authors postulate a
theory of direct interspecies infection with
influenza virus, between horses and humans.10,18
Authors further suggest that the influenza virus
acts as a zoonotic agent to facilitate its
propagation and perpetuation in nature.
Nowadays, the type B virus is also cited as
participating in the animal group which acts as
reservoir for influenza, this group includes
monkeys and seals.3,12
In addition to the cross-reaction (Ab till
40HIU) with both equine and human influenza
type A, the horses evaluated serologically in this
study, also presented protection (Ab=40HIU)
against both assayed non-specific or specific
strains. These animal sera were also able to
recognize the influenza virus type B/90, which
circulates in Brazil, that it was confirmed by the
standard B/83, (from Bethesda, MA, USA)
(Figure 1). Once more, these results revealed that
the human strains were introduced into the horses
through direct interspecie transmission. This fact
leads to suggest the zoonotic influenza ocurrence.
Thus, studies of the ecological properties of
influenza may be useful for to further
understanding of this viral disease and should
aid on its prevention into the human species in
the future.10 In order to evaluate the distribution
of the influenza virus in our environment, a
search for this virus in other natural hosts is being
carried out.
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Resumo
O objetivo deste estudo foi  investigar em cavalos, a incidência do vírus influenza e seu
ciclo de transmissão interespécies. Portanto, levantamento sorológico foi realizado em
Palavras-chave:
Influenza eqüina.
Influenza humana.
Teste da Inibição da
Hemaglutinação.
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Anti-human influenza protector antibody detected in horses as a zoonotic viruses
soro de cavalos, confrontados com ambas cepas, as específicas (eqüino) e não específicas
(humana) deste vírus. Sangrias de cavalos realizadas nos anos de 1999 e de 2000,
forneceram soros que, após tratamento com Caolim (20%) e  hemácias de galo(50%)
para remoção dos anticorpos inespecíficos, foram titulados contra ambas referidas
cepas, através do teste de Inibição da Hemaglutinação (recomendado pela OMS). Os
resultados, demonstraram que as respostas sorológicas dos cavalos apresentaram reação
cruzada entre as cepas específicas e as não específicas. As porcentagens de títulos  IH
obtidos foram de 62,75% e de 60,65% para as cepas específicas A/Eq1 (H7N7) e A/
Eq2 (H3N8), respectivamente. E às cepas não específicas essas porcentagens foram de:
79,05% para A (H1N1), de 94,45% para A (H3N2) e de 77,75% ao tipo B. O mais
relevante nestes dados comparativos com vírus influenza, foi a alta porcentagem de
resposta protetora à cepa não específica comparada àquela específica, detectada nos soros
eqüinos. Considerando o fato de que o tipo B, deste vírus, ser restrito à espécie humana,
portanto a resposta de proteção nos cavalos sugere uma direta transmissão interspécies,
como  em viroses zoonóticas. Os autores  relatam pela primeira vez este tipo de evento
no Brasil.
Reação Cruzada.
Resposta  de Proteção.
